Yan Du
Impact in
- Nephrology top 10%
- Acute Kidney Injury Research
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 4
- Co-authors
- Yongzhong Du (8 shared papers)Di Liu (8 shared papers)Xiaoling Xu (8 shared papers)Jing Qi (7 shared papers)Yuchan You (6 shared papers)Gaofeng Shu (5 shared papers)Feiyang Jin (5 shared papers)Xiaoying Ying (5 shared papers)
- Journals
- Phytomedicine (1 paper)Chemical Science (1 paper)Molecular Pharmaceutics (1 paper)Nature Communications (1 paper)Kidney & Blood Pressure Research (1 paper)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Yan Du
11 papers receiving 526 citations
Peers
Comparison fields: 5 of 79
- Nephrology 83
- Biomaterials 145
- Biomedical Engineering 310
- Physiology 28
- Immunology 92
Countries citing papers authored by Yan Du
This map shows the geographic impact of Yan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Du more than expected).
Fields of papers citing papers by Yan Du
This network shows the impact of papers produced by Yan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Du. The network helps show where Yan Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 161 | |
| 2 | 2021 | 122 | |
| 3 | 2021 | 105 | |
| 4 | 2020 | 43 | |
| 5 | 2020 | 26 | |
| 6 | 2021 | 26 | |
| 7 | 2021 | 21 | |
| 8 | 2021 | 16 | |
| 9 | 2017 | 7 | |
| 10 | 2025 | 1 | |
| 11 | [Epitope mapping of HIV-1 using phage-display random peptide library and the purified IgG from HIV patient]. | 2000 | 1 |
| 12 | Long-Term Survival After Nasopharyngeal Carcinoma Treatment in a Local Prefecture-Level Hospital in Southern China | 2020 | 0 |
About Yan Du
Yan Du is a scholar working on Biomedical Engineering, Molecular Biology, Nephrology, Pulmonary and Respiratory Medicine and Biomaterials, having authored 12 papers that have together received 529 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Photodynamic Therapy Research Studies (2 papers), Acute Kidney Injury Research (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Luminescence and Fluorescent Materials (1 paper), Renal Diseases and Glomerulopathies (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Nephrology (83 citations), Biomaterials (145 citations), Biomedical Engineering (310 citations), Physiology (28 citations) and Immunology (92 citations). Yan Du has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Yongzhong Du, Di Liu, Xiaoling Xu, Jing Qi, Yuchan You, Gaofeng Shu, Feiyang Jin, Xiaoying Ying, Jiansong Ji and Jun Wang. Their work appears in journals such as Phytomedicine, Chemical Science, Molecular Pharmaceutics, Nature Communications and Kidney & Blood Pressure Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.